Eveline K. Hoebe - Concepedia

Author

Eveline K. Hoebe

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

E K Hoebe, E. K. Hoebe, E.K. Hoebe, Eveline Hoebe, Eveline K Hoebe, Eveline K. Hoebe, Hoebe, Eveline

Publications

323

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam University of Georgia University of Wisconsin–Madison Universitas Gadjah Mada Taiho Pharmaceutical (Japan)

About

Eveline K. Hoebe is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, cancer research, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	120
2	Cell Biology	3	3	57
3	Natural Sciences	1	1	25
4	Biochemistry	1	1	25
5	Chemical Biology	1	1	25

Eveline K. Hoebe

Publications

261

Citations

H-Index

Page 1

	Year	Citations
Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells Olaf H. Temmink, Eveline K. Hoebe, Kasper van der Born, British Journal of Cancer	2007	50
Irinotecan-induced cytotoxicity to colon cancer cells in vitro is stimulated by pre-incubation with trifluorothymidine Olaf H. Temmink, Eveline K. Hoebe, Masakazu Fukushima, European Journal of Cancer OncologyIrinotecan-induced CytotoxicityOncogenic AgentMedicineColon Cancer Cells	2006	34
Purified Hexameric Epstein-Barr Virus-Encoded BARF1 Protein for Measuring Anti-BARF1 Antibody Responses in Nasopharyngeal Carcinoma Patients Eveline K. Hoebe, Susanna Hilda Hutajulu, Janko van Beek, Clinical and Vaccine Immunology	2010	29
Epstein-Barr Virus-Encoded BARF1 Protein is a Decoy Receptor for Macrophage Colony Stimulating Factor and Interferes with Macrophage Differentiation and Activation Eveline K. Hoebe, Tessa Y. S. Le Large, Nicolas Tarbouriech, Viral Immunology Viral PathogenesisImmunologyPathologyImmunologic MechanismImmunotherapy	2012	26
The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent J. Sigmond, J. A. E. Kamphuis, Adrianus C. Laan, Biochemical Pharmacology BiochemistryNatural SciencesProtein BiosynthesisMolecular BiologyDna Replication	2007	25
Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma Susanna Hilda Hutajulu, Eveline K. Hoebe, Sandra A.W.M. Verkuijlen, Infectious Agents and Cancer	2010	21
Epstein-Barr Virus Transcription Activator R Upregulates BARF1 Expression by Direct Binding to Its Promoter, Independent of Methylation Eveline K. Hoebe, Coral K. Wille, Erik Hopmans, Journal of Virology ImmunologyEpigeneticsCancer-associated VirusTranscriptional RegulationEpstein-barr Virus	2012	17
In Vitro Optimization of Non-Small Cell Lung Cancer Activity with Troxacitabine, <scp>l</scp>-1,3-Dioxolane-cytidine, Prodrugs Marco Radi, Auke D. Adema, Jonathan R. Daft, Journal of Medicinal Chemistry Tumor BiologyMedicinal ChemistryDrug TargetingAntitumor ActivityProdrug Strategies	2007	16
Epstein–Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma Eveline K. Hoebe, Coral K. Wille, Stacy R. Hagemeier, Cancers	2018	16
Staurosporine increases toxicity of gemcitabine in non-small cell lung cancer cells: role of protein kinase C, deoxycytidine kinase and ribonucleotide reductase J. Sigmond, Andries M. Bergman, Leticia G. León, Anti-Cancer Drugs Deoxycytidine KinaseCancer BiologyOxidative StressDck ActivityGemcitabine Sensitivity	2010	14

Page 1